24 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 24 of 24 clinical reviews.
A clinical review of the plausible interactions between alpha-lipoic acid and resmetirom (Rezdiffra), covering hypoglycemia risk, thyroid hormone effects, monitoring, and what still needs verification for patients with MASH.
A clinical review of the ashwagandha-resmetirom interaction, covering pharmacokinetic and pharmacodynamic concerns, thyroid effects, cortisol modulation, and practical monitoring guidance for patients on Rezdiffra.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between berberine and resmetirom (Rezdiffra) for patients managing MASH, including monitoring guidance and dose considerations.
A guide to the caffeine-resmetirom interaction: CYP1A2 pharmacokinetics, hemodynamic effects on a fibrotic liver, dose-timing strategies, and monitoring benchmarks for patients on Rezdiffra.
A guide to calcium and resmetirom (Rezdiffra) interactions, covering pharmacokinetics, dose-separation windows, monitoring parameters, and safety evidence for MASH patients.
Evidence-based guide to combining CoQ10 supplements with Rezdiffra (resmetirom) for MASH. Covers interaction risk, pharmacokinetics, dose-separation strategy, and monitoring.
A guide to the creatine and Rezdiffra (resmetirom) interaction, covering mechanism, creatinine monitoring, renal safety, and practical dosing guidance for patients with MASH.
A guide to combining folate with Rezdiffra (resmetirom) for MASH, covering pharmacokinetics, MTHFR status, dosing, monitoring, and safety.
A clinical review of the ginseng-resmetirom interaction: pharmacokinetic and pharmacodynamic risks, glucose monitoring, anticoagulant concerns, and what to do if you are already taking both.
A guide to combining glutathione supplements with Rezdiffra (resmetirom) for MASH: interaction mechanisms, safety evidence, dosing timing, and monitoring recommendations.
Evidence-based guide on combining glycine supplements with Rezdiffra (resmetirom) for MASH. Covers pharmacokinetic interactions, dose-separation, monitoring, and safety data.
A guide to the hepatotoxicity and pharmacokinetic risks of combining green tea extract or EGCG with resmetirom (Rezdiffra) for MASH, including dosing guidance, monitoring, and when to stop.
A guide to the L-theanine and resmetirom interaction: mechanism, safety evidence, monitoring, and practical dosing guidance for MASH patients.
A guide covering the pharmacokinetic and pharmacodynamic interaction between lion's mane mushroom and resmetirom (Rezdiffra), with dosing guidance, monitoring parameters, and safety recommendations for MASH patients.
A guide to magnesium and resmetirom (Rezdiffra) co-administration: interaction mechanism, safety evidence, dosing strategy, and monitoring recommendations for MASH patients.
A guide on the melatonin, resmetirom interaction: mechanisms, safety evidence, dosing timing, monitoring, and what to tell your prescriber.
Evidence-based guide on combining NAC supplements with Rezdiffra (resmetirom) for MASH. Covers drug-supplement interactions, pharmacokinetics, dosing windows, and monitoring recommendations.
What is known and not established about combining omega-3 fish oil (EPA/DHA) with Rezdiffra (resmetirom) for MASH, including monitoring guidance and open questions requiring pharmacist or clinician verification.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between reishi mushroom and resmetirom (Rezdiffra), with dosing guidance, monitoring protocols, and safety recommendations for MASH patients.
Resveratrol may inhibit CYP3A4 and alter resmetirom exposure. Learn about the pharmacokinetic interaction, dose-separation strategies, monitoring recommendations, and what to tell your prescriber if you already take both.
Evidence-based guide to taking turmeric or curcumin supplements alongside Rezdiffra (resmetirom) for MASH, including interaction risks, dose-separation strategies, and monitoring recommendations.
A clinical review of vitamin B12 safety, interactions, and monitoring when combined with resmetirom (Rezdiffra) for MASH. Written by the HealthRX.com medical team.
A guide to the vitamin B6 and resmetirom (Rezdiffra) interaction: pharmacokinetics, neuropathy risk, safe dosing, and monitoring recommendations for MASH patients.
A guide to taking vitamin D alongside Rezdiffra (resmetirom) for MASH: interaction mechanisms, safety evidence, monitoring tips, and dosing guidance.